116
Views
14
CrossRef citations to date
0
Altmetric
Original Investigations

Use of aripiprazole in tardive dyskinesia: An open label study of six cases

, , , , & , MD
Pages 416-419 | Received 25 Feb 2009, Published online: 08 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Alessandro Cuomo, Bruno Beccarini Crescenzi, Arianna Goracci, Simone Bolognesi, Nicola Giordano, Rodolfo Rossi, Edvige Facchi, Stephen M Neal & Andrea Fagiolini. (2019) Drug safety evaluation of aripiprazole in bipolar disorder. Expert Opinion on Drug Safety 18:6, pages 455-463.
Read now
Stanley N. Caroff, E. Cabrina Campbell & Benjamin Carroll. (2017) Pharmacological treatment of tardive dyskinesia: recent developments. Expert Review of Neurotherapeutics 17:9, pages 871-881.
Read now
Daniel P. Witter, Richard C. Holbert & Uma Suryadevara. (2017) Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients. Expert Opinion on Pharmacotherapy 18:10, pages 965-972.
Read now
Andrea Fagiolini, Roberto Brugnoli, Guido Di Sciascio, Sergio De Filippis & Giuseppe Maina. (2015) Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists. Expert Opinion on Pharmacotherapy 16:5, pages 727-737.
Read now

Articles from other publishers (10)

Ziad Ali, Autumn Roque & Rif S. El-Mallakh. (2020) A unifying theory for the pathoetiologic mechanism of tardive dyskinesia. Medical Hypotheses 140, pages 109682.
Crossref
Christian G. Widschwendter & Alex Hofer. (2019) Antipsychotic-induced tardive dyskinesia. Current Opinion in Psychiatry 32:3, pages 179-184.
Crossref
Chia-Hsiang Chan, Hung-Yu Chan & Yen-Ching Chen. (2018) Switching antipsychotic treatment to aripiprazole in psychotic patients with neuroleptic-induced tardive dyskinesia. International Clinical Psychopharmacology 33:3, pages 155-162.
Crossref
Roger Hudson, Yan Zhou & Francesco Leri. (2017) The combination of escitalopram and aripiprazole: Investigation of psychomotor effects in rats. Journal of Psychopharmacology 31:12, pages 1605-1614.
Crossref
MATTHEW MACALUSO, ALEXANDRA FLYNN & SHELDON PRESKORN. (2016) Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 4: Case Report Data. Journal of Psychiatric Practice 22:3, pages 203-220.
Crossref
Y. Auxéméry. (2011) Dyskinésies tardives secondaires aux neuroleptiques et antipsychotiques : quelles perspectives thérapeutiques ?. Annales Médico-psychologiques, revue psychiatrique 169:8, pages 528-535.
Crossref
Na-Ri Kang & Moon-Doo Kim. (2011) Tardive Dyskinesia: Treatment with Aripiprazole. Clinical Psychopharmacology and Neuroscience 9:1, pages 1-8.
Crossref
Noboru Imai & Masako Ikawa. (2011) Efficacy of Aripiprazole in Sulpiride-induced Tardive Oromandibular Dystonia. Internal Medicine 50:6, pages 635-637.
Crossref
Maria Sierra Peña, Toby C. Yaltho & Joseph Jankovic. (2010) Tardive dyskinesia and other movement disorders secondary to aripiprazole. Movement Disorders 26:1, pages 147-152.
Crossref
David M. Gardner, Michael D. Teehan & Ross Baldessarini. 2010. Antipsychotics and their Side Effects. Antipsychotics and their Side Effects 123 128 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.